Intravenous solithromycin Thorough QT (TQT) study

Trial Profile

Intravenous solithromycin Thorough QT (TQT) study

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Oct 2016

At a glance

  • Drugs Solithromycin (Primary) ; Moxifloxacin
  • Indications Bacterial infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 26 Oct 2016 Results published in the Journal of Antimicrobial Chemotherapy
    • 17 Apr 2015 According to a Cempra Pharmaceuticals media release, results from this trial will be presented at the 25th European Congress of Clinical Microbiology (ECCMID).
    • 21 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top